Literature DB >> 28673428

Indolent T-cell lymphoproliferative disease of the gastrointestinal tract in a renal transplant patient: diagnostic pitfalls and clinical challenges.

Gwyneth Soon1, Shi Wang2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28673428     DOI： 10.1016/j.pathol.2017.03.012

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  5 in total

1.  CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature.

Authors:  Chun-Yan Weng; Cheng Ye; Yi-Hong Fan; Bin Lv; Chun-Li Zhang; Meng Li
Journal:  World J Clin Cases       Date:  2022-05-26       Impact factor: 1.534

2.  Indolent T cell lymphoproliferative disorder of the gastrointestinal tract: an uncommon case with lymph node involvement and the classic Hodgkin's lymphoma.

Authors:  Jie Wu; Long-Guang Li; Xiang-Yan Zhang; Li-Li Wang; Li Zhang; Yu-Jing Xiao; Xiao-Ming Xing; Dong-Liang Lin
Journal:  J Gastrointest Oncol       Date:  2020-08

3.  Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report.

Authors:  Ryoichi Goto; Norio Kawamura; Masaaki Watanabe; Yasuyuki Koshizuka; Souichi Shiratori; Momoko Ara; Shohei Honda; Tomoko Mitsuhashi; Yoshihiro Matsuno; Tsuyoshi Shimamura; Akinobu Taketomi
Journal:  Surg Case Rep       Date:  2020-06-26

4.  Indolent T cell lymphoproliferative disorder with villous atrophy in small intestine diagnosed by single-balloon enteroscopy.

Authors:  Takashi Nagaishi; Daiki Yamada; Kohei Suzuki; Ryosuke Fukuyo; Eiko Saito; Masayoshi Fukuda; Taro Watabe; Naoya Tsugawa; Kengo Takeuchi; Kouhei Yamamoto; Ayako Arai; Kazuo Ohtsuka; Mamoru Watanabe
Journal:  Clin J Gastroenterol       Date:  2019-04-09

5.  Indolent T-cell lymphoproliferative disease with synchronous diffuse large B-cell lymphoma: A case report.

Authors:  Linjie Guo; Zhonghui Wen; Xueying Su; Shuyuan Xiao; Yufang Wang
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.